| Q33693965 | Antifungal susceptibilities of Paecilomyces species |
| Q54125126 | Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. |
| Q37889387 | Emerging moulds: epidemiological trends and antifungal resistance |
| Q33675579 | Fatal Hormonema dematioides peritonitis in a patient on continuous ambulatory peritoneal dialysis: criteria for organism identification and review of other known fungal etiologic agents |
| Q35622011 | Human hyalohyphomycoses: a review of human infections due to Acremonium spp., Paecilomyces spp., Penicillium spp., and Scopulariopsis spp. |
| Q33660358 | Outbreak of Paecilomyces variotii peritonitis in peritoneal dialysis patients after the 2010 Chilean earthquake |
| Q38118765 | Paecilomyces variotii as an Emergent Pathogenic Agent of Pneumonia |
| Q33971311 | Peritonitis due to Thermoascus taitungiacus (Anamorph Paecilomyces taitungiacus). |
| Q36269237 | Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections. |
| Q41222308 | Successful catheter reinsertion in a case of Paecilomyces varioti peritonitis in a patient on continuous ambulatory peritoneal dialysis |
| Q44135244 | Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome |